Sargent Investment Group LLC Sells 740 Shares of CVS Health Co. (NYSE:CVS)

Sargent Investment Group LLC decreased its position in CVS Health Co. (NYSE:CVS) by 14.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,303 shares of the pharmacy operator’s stock after selling 740 shares during the quarter. Sargent Investment Group LLC’s holdings in CVS Health were worth $254,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CVS. Edgestream Partners L.P. bought a new stake in CVS Health during the second quarter valued at about $1,140,000. Excalibur Management Corp boosted its stake in CVS Health by 3.4% during the 2nd quarter. Excalibur Management Corp now owns 45,784 shares of the pharmacy operator’s stock valued at $2,704,000 after purchasing an additional 1,526 shares during the period. Citizens Financial Group Inc. RI grew its holdings in CVS Health by 20.5% in the 2nd quarter. Citizens Financial Group Inc. RI now owns 39,261 shares of the pharmacy operator’s stock valued at $2,319,000 after buying an additional 6,670 shares during the last quarter. Mesirow Financial Investment Management Inc. increased its position in CVS Health by 1.1% in the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 148,522 shares of the pharmacy operator’s stock worth $8,778,000 after buying an additional 1,688 shares during the period. Finally, Waycross Partners LLC boosted its position in shares of CVS Health by 11.3% in the second quarter. Waycross Partners LLC now owns 207,539 shares of the pharmacy operator’s stock valued at $12,257,000 after acquiring an additional 21,135 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Trading Down 0.9 %

CVS stock opened at $57.85 on Wednesday. The business has a fifty day moving average price of $58.31 and a 200 day moving average price of $62.77. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The stock has a market capitalization of $72.62 billion, a price-to-earnings ratio of 10.17, a P/E/G ratio of 0.79 and a beta of 0.53.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the company posted $2.21 earnings per share. Analysts expect that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.60%. CVS Health’s dividend payout ratio (DPR) is currently 46.75%.

Analyst Upgrades and Downgrades

CVS has been the subject of several research analyst reports. Robert W. Baird started coverage on shares of CVS Health in a research note on Thursday, May 30th. They set a “neutral” rating and a $61.00 target price for the company. Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Evercore ISI lowered their price target on CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. Wells Fargo & Company raised their price objective on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Eleven analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $72.10.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.